Citation 78219

YOSHIKAWA,M: MURAKAMI,T: MATSUDA,H: UENO,T: KODAYA,M: YAMAHARA,J: MURAKAMI,N:. (1996). BIOACTIVE SAPONINS AND GLYCOSIDES. II. SENEGAE RADIX. (2): CHEMICAL STRUCTURES, HYPOGLYCEMIC ACTIVITY, AND ETHANOL ABSORPTION-INHIBITORY EFFECT OF E-SENEGASAPONIN C, Z-SENEGASAPONIN C, AND Z-SENEGINS II, III, AND IV.. 44(7)

Citation Details

Title	BIOACTIVE SAPONINS AND GLYCOSIDES. II. SENEGAE RADIX. (2): CHEMICAL STRUCTURES, HYPOGLYCEMIC ACTIVITY, AND ETHANOL ABSORPTION-INHIBITORY EFFECT OF E-SENEGASAPONIN C, Z-SENEGASAPONIN C, AND Z-SENEGINS II, III, AND IV.
Authors	YOSHIKAWA,M: MURAKAMI,T: MATSUDA,H: UENO,T: KODAYA,M: YAMAHARA,J: MURAKAMI,N:
Year	1996
Volume	44
Issue	7

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN II,TRANS:	ACTIVE
2	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN II,TRANS:	ACTIVE
3	Not specified	CMR SPECTRUM REPORTED	SENEGASAPONIN C,DEACYL:	None
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGASAPONIN C,DEACYL:	INACTIVE
5	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN IV,DEACYL:	INACTIVE
6	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN IV,DEACYL:	WEAK ACTIVITY
7	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN III,DEACYL:	INACTIVE
8	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN III,DEACYL:	WEAK ACTIVITY
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN IV,TRANS:	WEAK ACTIVITY
10	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN IV,TRANS:	WEAK ACTIVITY

Polygala senega (POLYGALACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SENEGASAPONIN C,TRANS:	None
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGASAPONIN C,TRANS:	WEAK ACTIVITY
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SENEGASAPONIN C,CIS:	None
5	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGASAPONIN C,CIS:	WEAK ACTIVITY
6	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	SENEGIN II,CIS:	None
7	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN II,CIS:	ACTIVE
8	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN II,CIS:	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTED	SENEGIN III,TRANS:	None
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN III,TRANS:	ACTIVE
11	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN III,TRANS:	WEAK ACTIVITY
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	SENEGIN III,CIS:	None
13	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN III,CIS:	ACTIVE
14	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN III,CIS:	WEAK ACTIVITY
15	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	SENEGIN IV,CIS:	None
16	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN IV,CIS:	ACTIVE
17	ETHANOL ABSORPTION DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	SENEGIN IV,CIS:	WEAK ACTIVITY
18	Not specified	ISOLATION AND IDENTIFICATION OF	SENEGASAPONIN A,TRANS:	None
19	Not specified	ISOLATION AND IDENTIFICATION OF	SENEGASAPONIN A,CIS:	None